DK0951284T3 - Phenylethylminderivater - Google Patents
PhenylethylminderivaterInfo
- Publication number
- DK0951284T3 DK0951284T3 DK97952645T DK97952645T DK0951284T3 DK 0951284 T3 DK0951284 T3 DK 0951284T3 DK 97952645 T DK97952645 T DK 97952645T DK 97952645 T DK97952645 T DK 97952645T DK 0951284 T3 DK0951284 T3 DK 0951284T3
- Authority
- DK
- Denmark
- Prior art keywords
- dementia
- alkyl
- hydrogen
- compounds
- directed
- Prior art date
Links
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 2
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 abstract 2
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 abstract 2
- 206010012289 Dementia Diseases 0.000 abstract 2
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 abstract 2
- 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 abstract 2
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 1
- 208000009829 Lewy Body Disease Diseases 0.000 abstract 1
- 201000002832 Lewy body dementia Diseases 0.000 abstract 1
- 206010039966 Senile dementia Diseases 0.000 abstract 1
- 208000000323 Tourette Syndrome Diseases 0.000 abstract 1
- 208000016620 Tourette disease Diseases 0.000 abstract 1
- 201000004810 Vascular dementia Diseases 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 230000006735 deficit Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 208000013403 hyperactivity Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
- C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
- C07C271/56—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL11985296A IL119852A0 (en) | 1996-12-18 | 1996-12-18 | Phenylethylamine derivatives |
| IL12050997A IL120509A0 (en) | 1997-03-24 | 1997-03-24 | Phenylethylamine derivatives |
| PCT/US1997/023897 WO1998026775A1 (en) | 1996-12-18 | 1997-12-18 | Phenylethylamine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0951284T3 true DK0951284T3 (da) | 2004-02-16 |
Family
ID=26323337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97952645T DK0951284T3 (da) | 1996-12-18 | 1997-12-18 | Phenylethylminderivater |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0951284B1 (da) |
| JP (1) | JP4116085B2 (da) |
| AT (1) | ATE251456T1 (da) |
| AU (1) | AU5620998A (da) |
| CA (1) | CA2275371C (da) |
| DE (1) | DE69725467T2 (da) |
| DK (1) | DK0951284T3 (da) |
| ES (1) | ES2208967T3 (da) |
| HU (1) | HU226526B1 (da) |
| PT (1) | PT951284E (da) |
| WO (1) | WO1998026775A1 (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030045449A1 (en) * | 2001-08-15 | 2003-03-06 | Pfizer, Inc. | Pharmaceutical combinations for the treatment of neurodegenerative diseases |
| US8097608B2 (en) | 2003-11-25 | 2012-01-17 | Technion Research And Development Foundation Ltd. | Methods for treatment of cardiovascular disorders and diseases |
| EP1686973A4 (en) * | 2003-11-25 | 2009-03-25 | Technion Res & Dev Foundation | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES AND DISEASES |
| JP2008526908A (ja) * | 2005-01-13 | 2008-07-24 | エフ．ホフマン−ラ ロシュ アーゲー | 有用な二置換アミンの新規な一段合成法 |
| CA2600603A1 (en) | 2005-02-24 | 2006-08-31 | Teva Pharmaceutical Industries Ltd. | Formulations of ladostigil tartrate |
| JP2009518433A (ja) | 2005-12-09 | 2009-05-07 | イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブライ ユニバーシティー オブ エルサレム | 神経保護用の低用量ラドスチギルの使用 |
| TW200744576A (en) | 2006-02-24 | 2007-12-16 | Teva Pharma | Propargylated aminoindans, processes for preparation, and uses thereof |
| CA3229910A1 (en) * | 2021-08-23 | 2023-03-02 | Alexander Shulgin Research Institute, Inc. | Fluorinated empathogens |
| CA3229907A1 (en) | 2021-08-23 | 2023-03-02 | Nicholas COZZI | Deuterated empathogens |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL6408165A (da) * | 1964-07-17 | 1966-01-18 | ||
| US3507962A (en) * | 1969-05-09 | 1970-04-21 | Thompson Chem Co Hayward | Controlling leafminer insects with selected carbamate insecticides,including 3,5-dimethyl-4-dimethylamino-methyl phenyl-n-methylcarbamate |
| IL74497A (en) * | 1985-03-05 | 1990-02-09 | Proterra Ag | Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives |
| HU201906B (en) * | 1987-03-04 | 1991-01-28 | Sandoz Ag | Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them |
-
1997
- 1997-12-18 DE DE69725467T patent/DE69725467T2/de not_active Expired - Lifetime
- 1997-12-18 EP EP97952645A patent/EP0951284B1/en not_active Expired - Lifetime
- 1997-12-18 AU AU56209/98A patent/AU5620998A/en not_active Abandoned
- 1997-12-18 JP JP52803898A patent/JP4116085B2/ja not_active Expired - Fee Related
- 1997-12-18 WO PCT/US1997/023897 patent/WO1998026775A1/en not_active Ceased
- 1997-12-18 PT PT97952645T patent/PT951284E/pt unknown
- 1997-12-18 ES ES97952645T patent/ES2208967T3/es not_active Expired - Lifetime
- 1997-12-18 CA CA002275371A patent/CA2275371C/en not_active Expired - Fee Related
- 1997-12-18 AT AT97952645T patent/ATE251456T1/de not_active IP Right Cessation
- 1997-12-18 HU HU0003180A patent/HU226526B1/hu not_active IP Right Cessation
- 1997-12-18 DK DK97952645T patent/DK0951284T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001506655A (ja) | 2001-05-22 |
| JP4116085B2 (ja) | 2008-07-09 |
| EP0951284B1 (en) | 2003-10-08 |
| HU226526B1 (en) | 2009-03-30 |
| EP0951284A4 (en) | 2002-03-20 |
| AU5620998A (en) | 1998-07-15 |
| HUP0003180A3 (en) | 2002-11-28 |
| PT951284E (pt) | 2003-12-31 |
| CA2275371C (en) | 2008-07-29 |
| CA2275371A1 (en) | 1998-06-25 |
| ES2208967T3 (es) | 2004-06-16 |
| HK1022838A1 (en) | 2000-08-25 |
| ATE251456T1 (de) | 2003-10-15 |
| DE69725467D1 (de) | 2003-11-13 |
| EP0951284A1 (en) | 1999-10-27 |
| WO1998026775A1 (en) | 1998-06-25 |
| DE69725467T2 (de) | 2004-07-22 |
| HUP0003180A2 (hu) | 2001-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT966435E (pt) | Derivados aminoindano | |
| ATE361287T1 (de) | Neue indol-2-on derivate | |
| NO994452D0 (no) | Substituerte 4-arylmetylen-2-imino-2,3-dihydrotiazoler og derivater, og deres farmasöytiske anvendelse | |
| ATE109466T1 (de) | Neue derivate des aminopiperidins, aminopyrrolidins und des aminoperhydroazepins, verfahren zur herstellung und diese enthaltende arzneimittel. | |
| IL111245A0 (en) | Cyclic amides and fungicidal compositions containing them | |
| DE68914292D1 (de) | Zusammensetzung zur Behandlung von ischämischen Störungen in Organen. | |
| NZ338016A (en) | Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same | |
| DE69305276D1 (de) | Arylglycinamidderivate, Verfahren zur deren Herstellung und deren Verwendung zur Therapie der Dysurie | |
| NO179707C (no) | Analogifremgangsmåte for fremstilling av antipicornavirale pyridazinaminer | |
| DK0951284T3 (da) | Phenylethylminderivater | |
| DE69326395D1 (de) | Spirooxathiolan-quinuclidin-Derivat zur Behandlung des Sjögren-Syndroms | |
| NO307464B1 (no) | Galantaminderivater, farmasøytisk sammensetning inneholdende samme samt deres anvendelse for fremstilling av medikamenter | |
| ATE218860T1 (de) | Verwendung von 3,4-diphenylchromanen zur herstellung eines arzneimittels zur behandlung bzw. vorbeugung des prostatakarzinoms | |
| KR970706826A (ko) | 포스포디에스테라제 IV 억제제로서의 디아제피노-인돌(Diazepino-Indoles as Phosphodiesterase Ⅳ Inhibitors) | |
| ATE8144T1 (de) | Indolobenzoxazine, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen. | |
| EP0658585A3 (de) | Amidinophenylalaninderivate, Verfahren zu deren Herstellung, deren Verwendung und diese enthaltende Mittel als Antikoagulantien. | |
| LV10235A (lv) | Jauni esteri to iegusanas panemiens farmaceitiska kompozicija arstesanas metode | |
| WO1999021848A3 (en) | Novel 1-(n'-(arylalkylaminoalkyl))aminoisoindoles; a new class of dopamine receptor subtype specific ligands | |
| NZ536524A (en) | Anticonvulsant and central nervous system-active bis(fluorophenyl)alkylamides | |
| DE69825879D1 (de) | Pharmazeutische zusammensetzungen welche aryl-substituierte olefinische amin-verbindungen enthalten | |
| ATE136904T1 (de) | Neue peptidderivate und deren pharmazeutischer gebrauch | |
| DE69327077D1 (de) | Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen | |
| FR2729665B1 (fr) | Nouveaux derives de glycylanilides, leur preparation et leur application en therapeutique | |
| HUP0101046A2 (hu) | Amiloidózis kezelésére alkalmazható amino-antraciklinon-származékok és ezeket tartalmazó gyógyszerkészítmények | |
| DE59308331D1 (de) | Verfahren zur Herstellung von 1-unsubstituierten 3-Aminopyrrolen |